Georg Wurschi

9PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Computational physiologyPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
Non-Cisplatin Concurrent Systemic Therapy with Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Network Meta-Analysis of Randomized Clinical Trials.

|Feb 18, 2026
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of life.

Georg W Wurschi, Andreas Hinz, Melanie Schneider

|Oct 29, 2025
CBCT-Based Online Adaptive, Ultra-Hypofractionated Radiotherapy for Prostate Cancer: First Clinical Experiences.

Georg Wurschi, Alexander Voigt, Noreen Murr

|Oct 25, 2025
Quality of life following total neoadjuvant therapy for rectal cancer.

Georg W Wurschi, Markus Diefenhardt, Justus Kaufmann

|Feb 26, 2025
Circulating Epithelial Tumor Cells (CETC/CTC) in Prostate Cancer: Potential Prognostic Marker for the Risk of Recurrence During Radiotherapy.

Dorothea Schott, Monika Pizon, Sonia Drozdz

|Apr 13, 2024
Patient-Relevant Costs for Organ Preservation versus Radical Resection in Locally Advanced Rectal Cancer.

Georg W Wurschi, Alexander Rühle, Justus Domschikowski

Pageof 2

Frequent Collaborators

3 joint publications

Maximilian Römer

2 joint publications

Klaus Pietschmann

2 joint publications

Alexander Rühle

2 joint publications

Felix Ehret